abstract |
Kainic acid neurocytotoxicity inhibitors containing as the active ingredient acyl-nitrogen-containing 5-membered heterocycle derivatives or pharmaceutically acceptable salts thereof; and 1-acyl-2-pyrazoline derivatives or pharmaceutically acceptable salts thereof. |